An Investigation into Blood-related Disorders in Individuals Diagnosed with Systemic Lupus Erythematosus (SLE).

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

Fahmia Feroz; Zahoor Ahmad Qazi; Syed Yunis Bukhari

An Investigation into Blood-related Disorders in Individuals Diagnosed with Systemic Lupus Erythematosus (SLE).

Authors: Fahmia Feroz, Zahoor Ahmad Qazi, Syed Yunis Bukhari

Unique Paper ID: 171975
Volume: 11
Issue: 8
PageNo: 1783-1789

Keywords: Systemic lupus erythematosus (SLE) thrombocytopenia leukopenia lymphopenia antiphospholipid antibodies renal dysfunction immunosuppressive therapies

Abstract:
Systemic lupus erythematosus (SLE) is a complex, chronic autoimmune disorder characterized by widespread inflammation and tissue damage, which can affect various organs, including the skin, kidneys, joints, and hematological system. Hematological complications are common in SLE patients and often play a critical role in disease management and prognosis. These complications include anemia, thrombocytopenia, leukopenia, lymphopenia, and the presence of antiphospholipid antibodies, which contribute to an increased risk of thromboembolic events. The aim of this study is to explore the frequency, types, and clinical implications of hematological disorders in SLE patients, as well as the association between these complications and overall disease activity. A retrospective analysis was conducted using clinical records and laboratory data from a cohort of SLE patients to identify the most prevalent blood-related complications and examine their correlation with disease severity, medication use, and long-term outcomes. The findings of this investigation suggest that hematological abnormalities are not only common in SLE but also significantly affect patient management and quality of life. Anemia, for example, is frequently observed and can result from a combination of chronic inflammation, iron deficiency, and renal dysfunction. Thrombocytopenia and leukopenia, on the other hand, may indicate active disease or side effects of immunosuppressive therapies. Additionally, the presence of lupus anticoagulant and antiphospholipid antibodies increases the risk of thrombosis, which complicates the treatment and management strategies for SLE patients. Understanding the nature and impact of hematological complications in SLE is crucial for the development of personalized treatment plans that address both the underlying disease and associated hematologic abnormalities. This study underscores the importance of comprehensive monitoring and early intervention to optimize clinical outcomes and improve the overall quality of life for patients living with SLE.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 8
PageNo: 1783-1789

An Investigation into Blood-related Disorders in Individuals Diagnosed with Systemic Lupus Erythematosus (SLE).

Available:https://ijirt.org/article?manuscript=171975

21 Mar, 2025

Artificial intelligence in identifying diabetes onset

18 Dec, 2024

A Study on Non-Pharmacological Methods to Reduce Pain in Pediatric Phlebotomy

14 Dec, 2024

Rare incidence of T cell lymphomas after chimeric antigen receptor (CAR)-T cell therapy

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now